Dapsone: Halted Phase I trial

Immune Network Ltd. (IMMKF; CDNX:IMM), Vancouver, B.C.
Product: Dapsone
Business: Neurological
Therapeutic category: Immune modulation
Target: Inflammatory enzymes

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE